Measurement techniques for monolithic microwave integrated circuits

Introduces the basic technologies that are associated with measurements of monolithic microwave integrated circuits. The use of test fixtures and wafer probe stations at ambient room temperature is reviewed and their role at thermal and cryogenic temperatures is discussed. With the increasing need for performing non-invasive measurements, advances in experimental field probing techniques are explored     

Advanced intelligent networks: now a reality

This paper looks first at the background to the development of intelligent networking concepts and then tracks this development to the advanced intelligent networks (AINs) of today. The network architecture and basic nodal functions are explained, and a brief review given of the essential intelligent network building blocks, namely the IN (intelligent network) call model and the enhanced CCITT No.7 signalling system. Typical intelligent network services are examined and the tutorial finishes with a review of the latest IN standards     

Uniplanar techniques for monolithic microwave integrated circuits

`Uniplanar' techniques have recently been introduced for the design of monolithic microwave integrated circuits (MMICs). The aim of these techniques is to achieve a higher level of integration of circuitry and to overcome the need for through-substrate via holes and the related back-face processing steps. This is achieved by using coplanar waveguide (CPW), slotline, and miniature `thin-film microstrip' transmission-line media as opposed to conventional microstrip. The design and performance of a number of uniplanar MMIC couplers, amplifiers, and other test circuits fabricated using the GEC-Marconi (Caswell) foundry are described     

Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. EORTC Lung Cancer Cooperative Group

26 previously treated patients with progressive recurrent small cell lung cancer (SCLC) were given vinorelbine (Navelbine), 30 mg/m2 weekly. All patients had responded to first-line chemotherapy and were off therapy for at least 3 months. Partial response was observed in 4 out of 25 eligible patients (16%; 95% confidence interval 4-36%), stable disease in 7 patients and progression in 12 patients. The limiting toxicity was a non-cumulative leucopenia (80%, 32% WHO grade 3-4). Reaction at the site of injection was observed in 5 patients, causing treatment discontinuation in 2 cases. Other non-haematological toxicities were moderate. These results suggest acceptable toxicity and some antitumour activity of vinorelbine in pretreated SCLC patients.